Literature DB >> 11911485

Betulinic acid sensitization of low pH adapted human melanoma cells to hyperthermia.

P R Wachsberger1, R Burd, M L Wahl, D B Leeper.   

Abstract

Betulinic acid is a known inducer of apoptosis in human melanoma that is most effective under conditions of low pH. It was hypothesized that betulinic acid, in combination with acute acidification and/or hyperthermia, would induce higher levels of apoptosis and cytotoxicity in low pH-adapted human melanoma cells than in cells grown at pH 7.3. DB-1 human melanoma cells, adapted to a tumour-like growth pH of 6.7, were exposed to hyperthermia (2h at 42 degrees C) and/or betulinic acid (4-10 microg/ml) and compared with cells grown at a physiological pH of 7.3 or after acute acidification from pH 7.3-6.3 or pH 6.7-6.3. Betulinic acid induced higher levels of apoptosis and cytotoxicity in low pH-adapted cells than in cells grown at pH 7.3, as measured by the terminal deoxynucleotidyl transferase (TdT) DNA fragmentation assay (TUNEL), the MTS cell viability assay, and single cell survival. Acute acidification of low pH adapted cells rendered them more susceptible to betulinic acid-induced apoptosis and cytotoxicity. In the presence of hyperthermia at 42 degrees C for 2 h, cells grown at pH 7.3 were not sensitized to heat killing by betulinic acid, whereas cells grown at pH 7.3 and acutely acidified to pH 6.3, cells adapted to growth at pH 6.7 and cells adapted to growth at pH 6.7 and acutely acidified to pH 6.3 were all similarly sensitized to heat killing by betulinic acid, with survival values of 5, 9 and 2%, respectively. It is concluded that betulinic acid may be useful in potentiating the therapeutic efficacy of hyperthermia as a cytotoxic agent in acidotic areas of tumours with minimal effect in normal tissues growing at pH 7.3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911485     DOI: 10.1080/02656730110091333

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  5 in total

1.  New ionic derivatives of betulinic acid as highly potent anti-cancer agents.

Authors:  Challa Suresh; Hua Zhao; Angelique Gumbs; Chellu S Chetty; Himangshu S Bose
Journal:  Bioorg Med Chem Lett       Date:  2011-12-28       Impact factor: 2.823

2.  C-lysine conjugates: pH-controlled light-activated reagents for efficient double-stranded DNA cleavage with implications for cancer therapy.

Authors:  Wang-Yong Yang; Boris Breiner; Serguei V Kovalenko; Chi Ben; Mani Singh; Shauna N LeGrand; Qing-Xiang Amy Sang; Geoffrey F Strouse; John A Copland; Igor V Alabugin
Journal:  J Am Chem Soc       Date:  2009-08-19       Impact factor: 15.419

Review 3.  Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches.

Authors:  Ga Yeong Yi; Min Ju Kim; Hyo In Kim; Jinbong Park; Seung Ho Baek
Journal:  Antioxidants (Basel)       Date:  2022-03-24

4.  Thermosensitive Betulinic Acid-Loaded Magnetoliposomes: A Promising Antitumor Potential for Highly Aggressive Human Breast Adenocarcinoma Cells Under Hyperthermic Conditions.

Authors:  Claudia Geanina Farcas; Cristina Dehelean; Iulia Andreea Pinzaru; Marius Mioc; Vlad Socoliuc; Elena-Alina Moaca; Stefana Avram; Roxana Ghiulai; Dorina Coricovac; Ioana Pavel; Praveen Kumar Alla; Octavian Marius Cretu; Codruta Soica; Felicia Loghin
Journal:  Int J Nanomedicine       Date:  2020-10-23

5.  Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice.

Authors:  N Sawada; K Kataoka; K Kondo; H Arimochi; H Fujino; Y Takahashi; T Miyoshi; T Kuwahara; Y Monden; Y Ohnishi
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.